Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation TCT 2025

How Does Real World Evidence Fit into the Regulatory Pathway?

Presenter: David J. Cohen

October 28, 2025

Presentation TCT 2025

TCT 1047: Rising Use of Thrombectomy in Acute Pulmonary Embolism: Mortality Benefits in Cor Pulmonale and the Role of Hyponatremia

Presenter: Brett David Cohen

October 28, 2025

Presentation TCT 2025

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Presenter: David J. Cohen

October 27, 2025

Presentation TCT 2025

Clinical Research After TRISCEND: Highest Priority Clinical Questions

Presenter: David J. Cohen

October 26, 2025

Presentation TCT 2025

Current Status of Long-Term PCI Outcomes: Why it is Time to Rethink PCI Success

Presenter: David J. Cohen

October 26, 2025

Presentation TCT 2025

TCT 299: Impact of Coronary Artery Bypass Graft and Cardiac Catheterization Timing on Mortality and Disability in NSTEMI Patients

Presenter: Brett David Cohen

October 26, 2025

Presentation TCT 2025

Power in Partnership: Why I Champion the Cardiovascular Team

Presenter: David J. Cohen

October 25, 2025

Presentation NY Valves 2025

What Are the Next Clinical Trials Needed in the Tricuspid Space?

Presenter: David J. Cohen

June 26, 2025

Presentation NY Valves 2025

Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry

Presenter: David J. Cohen

June 25, 2025

Presentation Fellows 2025

Potpourri of Lessons Learned from Impactful Trials in Interventional Cardiology

Presenter: David J. Cohen

May 18, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Opinion Conversations in Cardiology

Cath Lab Attire: ‘Dress Up and Shut Up’ or Time for a Change?

March 28, 2025

News Features

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Yael L. Maxwell

March 27, 2025

News Conference News CRT 2025

STEMI Revascularization Times All Over the Map: GWTG Registry

L.A. McKeown

March 14, 2025

News Conference News CRT 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

L.A. McKeown

March 12, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

Presentation THT 2025

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: David Cohen

February 13, 2025

News Daily News

Early Actions by Trump Administration Sow Uncertainty for CV Research

Todd Neale

January 30, 2025

Advertisement

How Does Real World Evidence Fit into the Regulatory Pathway?

TCT 1047: Rising Use of Thrombectomy in Acute Pulmonary Embolism: Mortality Benefits in Cor Pulmonale and the Role of Hyponatremia

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Clinical Research After TRISCEND: Highest Priority Clinical Questions

Current Status of Long-Term PCI Outcomes: Why it is Time to Rethink PCI Success

TCT 299: Impact of Coronary Artery Bypass Graft and Cardiac Catheterization Timing on Mortality and Disability in NSTEMI Patients

Power in Partnership: Why I Champion the Cardiovascular Team

What Are the Next Clinical Trials Needed in the Tricuspid Space?

Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry

Potpourri of Lessons Learned from Impactful Trials in Interventional Cardiology

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Cath Lab Attire: ‘Dress Up and Shut Up’ or Time for a Change?

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

STEMI Revascularization Times All Over the Map: GWTG Registry

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Early Actions by Trump Administration Sow Uncertainty for CV Research

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content